Quiet Therapeutics

About:

Quiet Therapeutics is an emerging biotech company founded in 2010 developing a proprietary nanoparticle-based delivery system.

Website: http://quietx.com/

Top Investors: Arkin Holdings, Jerusalem Global Ventures

Description:

Quiet Therapeutics is an emerging biotech company founded in 2010 developing a proprietary nanoparticle-based delivery system (gagomers) focused on oncology and inflammation. Based on the targeting capability of our innovative technology, the company is well positioned to expand the drug target repertoire in cancer and inflammation. The Gagomer delivery approach enables us to target cell components that are not manageable by other therapeutic agents like small molecules or antibodies.

Total Funding Amount:

$17.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ness Ziona, HaMerkaz, Israel

Founded Date:

2009-01-01

Contact Email:

ron(AT)quietx.com

Founders:

Dan Peer

Number of Employees:

1-10

Last Funding Date:

2015-04-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai